Profil

Arslan Deniz

See author's contact details
Main Referenced Co-authors
Pirotte, Bernard  (18)
De Tullio, Pascal  (13)
Lambert, Vincent  (12)
Noël, Agnès  (12)
Elmoualij, Benaïssa  (9)
Main Referenced Keywords
AMD (7); Metabolomics (5); Metabolomic (4); PDHK (3); PDHK Inhibitors (2);
Main Referenced Unit & Research Centers
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège [BE] (5)
Centre Interfacultaire de Recherche du Médicament - CIRM (5)
Institut de recherches Servier (1)
Laboratoire de Chimie Pharmaceutique, CIRM, Université de Liège (1)
Main Referenced Disciplines
Pharmacy, pharmacology & toxicology (19)
Computer science (1)

Publications (total 19)

The most downloaded
113 downloads
Arslan, D., Schoumacher, M., Dilly, S., Elmoualij, B., Zorzi, D., Quatresooz, P., Lambert, V., Noël, A., Pirotte, B., & De Tullio, P. (2023). Design, Synthesis, and Evaluation of Novel Pyruvate Dehydrogenase Kinase Inhibitors. Medicinal Chemistry, 19 (3), 276-296. doi:10.2174/1573406418666220819102627 https://hdl.handle.net/2268/294183

The most cited

31 citations (Scopus®)

Renard, J.-F., Arslan, D., Garbacki, N., Pirotte, B., & de Leval, X. (2009). Pyridine analogues of nimesulide: design, synthesis, and in vitro and in vivo pharmacological evaluation as promising cyclooxygenase 1 and 2 inhibitors. Journal of Medicinal Chemistry, 52, 5864-5871. doi:10.1021/jm900702b https://hdl.handle.net/2268/29976

Arslan, D., Schoumacher, M., Dilly, S., Elmoualij, B., Zorzi, D., Quatresooz, P., Lambert, V., Noël, A., Pirotte, B., & De Tullio, P. (2023). Design, Synthesis, and Evaluation of Novel Pyruvate Dehydrogenase Kinase Inhibitors. Medicinal Chemistry, 19 (3), 276-296. doi:10.2174/1573406418666220819102627
Peer Reviewed verified by ORBi

Arslan, D., LAMBERT, V., Noël, A., Pirotte, B., De Tullio, P., Zorzi, D. (Other coll.), & Hansen, S. (Other coll.). (11 December 2019). From Metabolomics Study of Age Related Macular Degeneration (AMD) to the Development of New Pyruvate Dehydrogenase Kinase (PDK) Inhibitors [Poster presentation]. 2nd CIRM-day.

Arslan, D., LAMBERT, V., Noël, A., Pirotte, B., De Tullio, P., Schoumacher, M. (Other coll.), Hansen, S. (Other coll.), & Elmoualij, B. (Other coll.). (19 December 2018). From Metabolomics Study of Age Related Macular Degeneration (AMD) to the Development of New Pyruvate Dehydrogenase Kinase (PDK) Inhibitors [Paper presentation]. 1st CIRM DAY.

Arslan, D., LAMBERT, V., Elmoualij, B., Noël, A., Pirotte, B., De Tullio, P., Schoumacher, M. (Other coll.), & Hansen, S. (Other coll.). (23 November 2018). From Metabolomics Study of Age Related Macular Degeneration (AMD) to the Development of New Pyruvate Dehydrogenase Kinase Inhibitors (PDK) [Poster presentation]. MedChem 2018 New Avenues in Kinase Drug Discovery: a Bright Future ?.

LAMBERT, V., Schoumacher, M., Lecomte, J., Arslan, D., Leenders, J., Govaerts, B., RAKIC, J.-M., Noël, A., & De Tullio, P. (19 September 2018). Metabolomics for the discovery of new therapeutic approach and personalized medicine: the case of exudative Age-related Macular Degeneration [Paper presentation]. Benelux metabolomics Days, Netherlands.

Arslan, D., Schoumacher, M., Pirotte, B., De Tullio, P., Hansen, S. (Other coll.), LAMBERT, V. (Other coll.), Elmoualij, B. (Other coll.), & Noël, A. (Other coll.). (14 September 2017). From Metabolomics Study of Age-Related Macular Degeneration (AMD) to the Development of New Pyruvate Dehydrogenase Kinase Inhibitors (PDK) [Poster presentation]. 31éme ournée Franco-Belge de Pharmacochimie, SPA, Belgium.

Arslan, D., Schoumacher, M., Pirotte, B., De Tullio, P., Hansen, S. (Other coll.), LAMBERT, V. (Other coll.), Elmoualij, B. (Other coll.), & Noël, A. (Other coll.). (May 2016). From Metabolomics Study of Age-Related Macular Degeneration (AMD) to the Development of New Pyruvate Dehydrogenase Kinase Inhibitors (PDK) [Poster presentation]. JFB 2016 : 30èmes Journées Franco-Belges de Pharmacochimie, Amboise, France.

Arslan, D., Schoumacher, M., Pirotte, B., De Tullio, P., Hansen, S. (Other coll.), LAMBERT, V. (Other coll.), Elmoualij, B. (Other coll.), & Noël, A. (Other coll.). (12 November 2015). FROM METABOLOMICS STUDY OF AGE RELATED MACULAR DEGENERATION (AMD) TO THE DEVELOPMENT OF NEW PDK INHIBITORS [Poster presentation]. International Gazi Pharma Symposium Series, Antalya, Turkey.

Schoumacher, M., Arslan, D., De Tullio, P., Hansen, S. (Other coll.), LAMBERT, V. (Other coll.), Elmoualij, B. (Other coll.), Noël, A. (Other coll.), & Pirotte, B. (Other coll.). (June 2015). From Metabolic Study of Age-Related Macular Degeneration (AMD) to Development of New PDH Kinase Inhibitors [Poster presentation]. 29ème Journées Franco-Belge de Pharmacochimie, Spa, Belgium.

Arslan, D., Pirotte, B., De Tullio, P., Charif, M. (Other coll.), Dilly, S. (Other coll.), Hansen, S. (Other coll.), LAMBERT, V. (Other coll.), Elmoualij, B. (Other coll.), & Noël, A. (Other coll.). (09 September 2014). AGE-RELATED MACULAR DEGENERATION (AMD): FROM METABOLOMICS APPROACH TO THE INHIBITION OF PDK AS A NEW THERAPEUTIC TARGET [Poster presentation]. XXIII International Symposium on Medicinal Chemistry (EFMC-ISMC 2014), Lisbonne, Portugal.

Arslan, D., Pirotte, B., De Tullio, P., Charif, M. (Other coll.), Dilly, S. (Other coll.), Hansen, S. (Other coll.), LAMBERT, V. (Other coll.), Elmoualij, B. (Other coll.), & Noël, A. (Other coll.). (June 2014). Inhibition of PDH Kinase as a new therapeutic target for Age-related Macular Degeneration (AMD) [Poster presentation]. 28e Journées franco-belges de Pharmacochimie, Communauté de Metz Métropole, France.

Arslan, D., Dilly, S., LAMBERT, V., Hansen, S., RAKIC, J.-M., Noël, A., Govaerts, B., Pirotte, B., & De Tullio, P. (06 June 2013). Age-related Macular Degeneration (AMD): from Metabolomics approach to the inhibition of PDH Kinase as a new therapeutic target [Poster presentation]. 27e Journées franco-belges de Pharmacochimie, Lille, France.

Renard, J.-F., Lecomte, F., Arslan, D., Hubert, P., & Pirotte, B. (May 2012). Evaluation de l'impact au niveau pharmacocinétique de modulations structurales de N-(pyrid-4-yl)alcanesulfonamides [Poster presentation]. 26èmes Journées franco-belges de pharmacochimie, Orléans, France.

Dintilhac, G., Arslan, D., Dilly, S., Danober, L., Botez, I., Lestage, P., Pirotte, B., & De Tullio, P. (2011). New substituted aryl esters and aryl amides of 3,4-dihydro-2H-1,2,4- benzothiadiazine 1,1-dioxides as positive allosteric modulators of AMPA receptors. MedChemComm, 2, 509. doi:10.1039/c1md00069a
Peer Reviewed verified by ORBi

Renard, J.-F., Arslan, D., Garbacki, N., De Leval, X., & Pirotte, B. (May 2009). Developpement d’inhibiteurs de cyclooxygénases: les analogues pyridiniques du nimésulide [Poster presentation]. 23èmes Journées Franco-Belges de Pharmacochimie, Mons, Belgium.

Renard, J.-F., Arslan, D., Garbacki, N., Pirotte, B., & de Leval, X. (2009). Pyridine analogues of nimesulide: design, synthesis, and in vitro and in vivo pharmacological evaluation as promising cyclooxygenase 1 and 2 inhibitors. Journal of Medicinal Chemistry, 52, 5864-5871. doi:10.1021/jm900702b
Peer Reviewed verified by ORBi

Renard, J.-F., Arslan, D., Garbacki, N., De Leval, X., & Pirotte, B. (May 2008). (N-pyridinyl)alkanesulfonamides as potent anti-inflammatory drugs [Poster presentation]. 22èmes Journées Franco-Belges de Pharmacochimie, Caen, France.

Renard, J.-F., Arslan, D., Garbacki, N., de Leval, X., & Pirotte, B. (May 2007). Conception, synthèse et évaluation pharmacologique in vitro et in vivo d’analogues pyridiniques du nimésulide [Poster presentation]. 21èmes Journées Franco-Belges de Pharmacochimie, Namur, Belgium.

Renard, J.-F., Arslan, D., Garbacki, N., de Leval, X., & Pirotte, B. (2007). Conception, synthèse et évaluation pharmacologique in vitro et in vivo d’analogues pyridiniques du nimésulide [Poster presentation]. 21èmes Journées Franco-Belges de Pharmacochimie, Namur, Belgium.

Contact ORBi